Nitazoxanide and Lansoprazole Based Regimens for H. Pylori Management
Condition:   Helicobacter Pylori Interventions:   Drug: Naïve patients - ACO therapy;   Drug: Naïve patients - LNDL therapy;   Drug: Naïve patients - MNDL therapy;   Drug: Treatment-experienced patients- LNDL therapy;   Drug: Treatment-experienced patients- MNDL therapy Sponsors:   National Liver Institute, Egypt;   Future pharmaceutical industries Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 11, 2022 Category: Research Source Type: clinical trials

A Study in Patients With Reflux Esophagitis to Investigate Safety, Tolerability, and Healing Rates After 4 Weeks Treatment of X842 or Lansoprazole and Symptom Pattern During Subsequent 4 Weeks Treatment With Lansoprazole
Condition:   Reflux Esophagitis Interventions:   Drug: X842;   Drug: X842 Dummy;   Drug: Lansoprazole;   Drug: Lansoprazole Dummy Sponsors:   Cinclus Pharma AG;   Parexel Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 24, 2021 Category: Research Source Type: clinical trials